Why the study?
Does coronary bypass surgery improve morbidity, mortality, and employment in patients with stable angina pectoris compared to medical therapy?
Does coronary bypass surgery improve morbidity, mortality, and employment in patients with stable angina pectoris compared to medical therapy?
Coronary bypass surgery significantly reduces mortality and improves employment and symptoms compared to medical therapy in patients with stable angina pectoris over 5 years.
Favors coronary bypass over medical therapy in stable angina; confirms survival and employment benefits in this RCT.
The effects of coronary bypass surgery on morbidity, mortality and employment were assessed in a randomized prospective 5-year study. Exercise tolerance showed an immediate, striking improvement, which was maintained throughout the follow-up period. Corresponding patients treated with medical therapy showed no change. More than 40 percent of patients in the surgical group were free from symptoms over the five years. The annual mortality of the surgical patients was 0.8 percent as compared with 4.0 percent in the medical patients (p less than 0.05). The annual mortality of the intensively treated medical patients with multivessel disease was not significantly higher than the 3.1 percent for a group of patients with single-vessel disease followed concomitantly. The rate of work at 5 years after bypass surgery was 47 percent as compared with only 18 percent in the randomized medically treated group (p less than 0.01). It is concluded that coronary bypass surgery reduces morbidity and mortality and improves employment.
No takes yet. Share an insight, caveat, or question.
Frick et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: